Cargando…
Short-term glucocorticoid excess blunts abaloparatide-induced increase in femoral bone mass and strength in mice
Glucocorticoids (GCs), such as prednisolone, are widely used to treat inflammatory diseases. Continuously long-term or high dose treatment with GCs is one of the most common causes of secondary osteoporosis and is associated with sarcopenia and increased risk of debilitating osteoporotic fragility f...
Autores principales: | Brent, Mikkel Bo, Thomsen, Jesper Skovhus, Brüel, Annemarie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192916/ https://www.ncbi.nlm.nih.gov/pubmed/34112892 http://dx.doi.org/10.1038/s41598-021-91729-8 |
Ejemplares similares
-
Teriparatide and Abaloparatide Have a Similar Effect on Bone in Mice
por: Brent, Mikkel Bo, et al.
Publicado: (2021) -
The Efficacy of PTH and Abaloparatide to Counteract Immobilization-Induced Osteopenia Is in General Similar
por: Brent, Mikkel Bo, et al.
Publicado: (2020) -
The effect of oral dabigatran etexilate on bone density, strength, and microstructure in healthy mice
por: Brent, Mikkel Bo, et al.
Publicado: (2017) -
Animal models of disuse-induced bone loss: study protocol for a systematic review
por: Brent, Mikkel Bo, et al.
Publicado: (2020) -
Effect of Acetazolamide and Zoledronate on Simulated High Altitude-Induced Bone Loss
por: Brent, Mikkel Bo, et al.
Publicado: (2022)